207 related articles for article (PubMed ID: 11788926)
1. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis.
Parravicini E; van de Ven C; Anderson L; Cairo MS
Transfus Med Rev; 2002 Jan; 16(1):11-24. PubMed ID: 11788926
[TBL] [Abstract][Full Text] [Related]
2. The role of cytokines in modulating neonatal myelopoiesis and host defense.
Rosenthal J; Cairo MS
Cytokines Mol Ther; 1995 Sep; 1(3):165-76. PubMed ID: 9384673
[TBL] [Abstract][Full Text] [Related]
3. Potential use of granulocyte colon-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates.
Bracho F; Goldman S; Cairo MS
Curr Opin Hematol; 1998 May; 5(3):215-20. PubMed ID: 9664163
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in the prophylaxis and treatment of neonatal sepsis.
Suri M; Harrison L; Van de Ven C; Cairo MS
Curr Opin Pediatr; 2003 Apr; 15(2):155-60. PubMed ID: 12640271
[TBL] [Abstract][Full Text] [Related]
5. Myeloid colony-stimulating factors: use in the newborn.
Sreenan C; Osiovich H
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulins and haematopoietic growth factors in the prevention and treatment of neonatal sepsis: ground reality or glorified myths?
Shaw CK; Thapalial A; Shaw P; Malla K
Int J Clin Pract; 2007 Mar; 61(3):482-7. PubMed ID: 17313617
[TBL] [Abstract][Full Text] [Related]
7. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
Lehrnbecher T
Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
[TBL] [Abstract][Full Text] [Related]
8. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis.
Banerjea MC; Speer CP
Semin Neonatol; 2002 Aug; 7(4):335-49. PubMed ID: 12401303
[TBL] [Abstract][Full Text] [Related]
9. Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis.
Goldman S; Ellis R; Dhar V; Cairo MS
Clin Perinatol; 1998 Sep; 25(3):699-710. PubMed ID: 9779342
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of expression of immunoregulatory and cytokine genes and its association with the immaturity in neonatal phagocytic and cellular immunity.
Satwani P; Morris E; van de Ven C; Cairo MS
Biol Neonate; 2005; 88(3):214-27. PubMed ID: 16210844
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
12. The effects of recombinant human granulocyte-macrophage colony stimulating factor on the neutrophil respiratory burst in the term and preterm infant when studied in whole blood.
Jaswon MS; Jones HM; Linch DC
Pediatr Res; 1994 Nov; 36(5):623-7. PubMed ID: 7877882
[TBL] [Abstract][Full Text] [Related]
13. Use of myeloid colony-stimulating factors in neonates with septicemia.
Bernstein HM; Calhoun DA; Christensen RD
Curr Opin Pediatr; 2002 Feb; 14(1):91-4. PubMed ID: 11880741
[TBL] [Abstract][Full Text] [Related]
14. Sepsis in babies: should we stimulate the phagocytes?
Shann F
Lancet; 2009 Jan; 373(9659):188-90. PubMed ID: 19150690
[No Abstract] [Full Text] [Related]
15. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
Ahmad M; Fleit HB; Golightly MG; La Gamma EF
Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic colony-stimulating factors.
Kaushansky K; Brown CB; Petersdorf S
Biotechnology; 1991; 19():365-95. PubMed ID: 1723913
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
Ahmad A; Laborada G; Bussel J; Nesin M
Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
[TBL] [Abstract][Full Text] [Related]
18. The new generation of recombinant human hematopoietic cytokines.
Hunt P; Foote M
Curr Opin Biotechnol; 1995 Dec; 6(6):692-7. PubMed ID: 8527842
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic growth factor levels in term and preterm infants.
Rondini G; Chirico G
Curr Opin Hematol; 1999 May; 6(3):192-7. PubMed ID: 10226741
[TBL] [Abstract][Full Text] [Related]
20. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
